Natural killer cells and their role in graft rejection

Current Opinion in Immunology

Volumn 10, Issue 5, 1998, Pages 532-538

  Manilay, Jennifer O ^a   Sykes, Megan ^a  

^a Transplantation Biology Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; PROTEIN GLYCOSYLATION; REVIEW; XENOTRANSPLANTATION;

EID: 0031754827     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80219-7     Document Type: Article

References (77)

1. Georgopoulos K, Bigby M, Wang J-H, Molnar A, Wu P, Winandy S, Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 79:1994;143-156.
2. Trincheri G. Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin Immunol. 7:1995;83-88.
3. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu Rev Immunol. 10:1993;189-213.
4. Ohlen C, Kling G, Hoglund P, Hansson M, Scangos G, Bieberich C, Jay G, Karre K. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science. 246:1989;666-668.
5. -/- cells had developed.
6. Kung SKP, Miller RG. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo. of special interest J Immunol. 158:1997;2616-2626 Hybrid resistance is the phenomenon by which F1 (AxB) NK cells reject parental (A or B) bone marrow grafts. In this study bone marrow chimeras were prepared using F1 (BALB/c x B6) cells injected into BALB/c mice or F1 cells injected into B6 mice, to assess whether F1 NK cells developing in the parental host would be tolerant of parental targets. Both sets of chimeras were challenged with a mixture of B6 and BALB/c cells labeled with fluorescein isothiocyanate. In both cases, parental targets syngeneic to the host were removed less effectively by the F1 NK cells developing in that parental host, suggesting that the F1 NK cells were tolerant to the host; however, in vitro lymphokine-activated killer cell (LAK) cultures of the F1 NK cells from chimeras showed no such specificity.
7. Chadwick BS, Miller RG. Hybrid resistance in vitro: possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol. 148:1992;2307-2313.
8. - bone marrow in chimeric mice. Proc Natl Acad Sci USA. 88:1991;10332-10336.
9. Lao N-S, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science. 253:1991;199-202.
10. Leibson PJ. MHC-recognizing receptors: they're not just for T cells anymore. Immunity. 3:1995;5-8.
11. Takei F, Brennan J, Mager DL. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol Rev. 155:1997;67-77.
12. Long EO, Burshtyn DN, Clark WP, Peruzzi M, Rajagopalan S, Rojo S, Wagtmann N, Winter CC. Killer cell inhibitory receptors: diversity, specificity and function. Immunol Rev. 155:1997;135-144.
13. Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol. 156:1996;4531-4534.
14. Sundback J, Karre K, Sentman CL. Cloning of minimally divergent allelic forms of the natural killer (NK) receptor Ly-49C, differentially controlled by host genes in the MHC and NK gene complexes. J Immunol. 157:1996;3936-3942.
15. Stoneman ER, Bennett M, An J, Chesnut KA, Wakeland EK, Scheerer JB, Siciliano MJ, Kumar V, Mathew PA. Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med. 182:1995;305-313.
16. Smith HRC, Karlhofer FM, Yokoyama WM. Ly-49 multigene family expressed by IL-2-activated NK cells. J Immunol. 153:1994;1068-1079.
17. Mason LH, Ortaldo JR, Young HA, Kumar V, Bennett M, Anderson SK. Cloning and functional characterization of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J Exp Med. 182:1995;293-303.
18. Brennan J, Lemieux S, Freeman JD, Mager DL, Takei F. Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with differing functions and expression patterns. J Exp Med. 184:1996;2085-2090.
19. Valiante NM, Lienert K, Shilling HG, Smits BJ, Parham P. Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev. 155:1997;155-164.
20. Dohring C, Scheidegger D, Samardis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol. 156:1996;3098-3101.
21. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, Di Donato C, Accame L, Bottino C, Moretta A, Moretta L. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med. 184:1996;505-518.
22. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:1995;405-408.
23. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity. 3:1995;801-809.
24. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B and HLA-C allotypes. Immunity. 5:1996;163-172.
25. Soderstrom K, Corliss B, Lanier LL, Phillips JH. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol. 159:1997;1072-1075.
26. Vance RE, Tanamachi DM, Hanke T, Raulet DH. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol. 27:1997;3236-3241.
27. Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol. 27:1997;1875-1880.
28. + NK clones. This paper demonstrated that the predominant ligand of CD94 - NKG2A, NKG2B or NKG2C is HLA-E.
29. Wang LL, Mehta IK, LeBlanc PA, Yokoyama WM. Mouse natural killers cells express gp49B1, a structural homologue of human killer inhibitory receptors. J Immunol. 158:1997;13-17.
30. Rojo S, Burshtyn DN, Long EO, Wagtmann N. Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells. J Immunol. 158:1997;9-12.
31. Arm JP, Nwankwo C, Austen KF. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J Immunol. 159:1997;2342-2349.
32. Sykes M, Harty MW, Karlhofer FM, Pearson DA, Szot G, Yokoyama W. Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J Exp Med. 178:1993;223-229.
33. Ciccone E, Pende D, Viale O, Di Donato C, Tripodi G, Orengo AM, Guardiola J, Moretta A, Moretta L. Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: Definition of five distinct NK-determined allospecificities in humans. J Exp Med. 175:1992;709-718.
34. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogenity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med. 178:1993;1321-1336.
35. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. of outstanding interest Immunity. 7:1997;739-751 In this study, natural killer (NK) cell clones were derived from two human donors and the killer inhibitory receptors (KIRs) expressed by each donor were analyzed. The repertoires from these donors were distinct from each other, as one donor expressed one KIR MHC-ligand and expressed mainly the CD94 - NKG2A receptor on NK cells; while the other expressed three KIR MHC-ligands and used the immunoglobulin superfamily receptors as NK inhibitory receptors. NK cells from the donor expressing mainly the CD94 - NKG2A receptor, which is more broadly reactive than the immunoglobulin superfamily inhibitory receptors, were unable to lyse target cells from the other donor. These results suggest that NK cells bearing CD94 - NKG2A receptors may be tolerant to most HLA-expressing targets.
36. - cells were separated, before culture in IL-2. These data suggest that NK cell tolerance is dependent on constant NK cell interactions with MHC molecules in their environment.
37. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 182:1995;875-884.
38. Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, Rodriguez A, Perez-Villar JJ, Moretta L, Moretta A, Lopez-Botet M. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol. 27:1997;563-567.
39. Mason LH, Anderson SK, Yokoyama WM, Smith HRC, Winkler-Pickett R, Ortaldo JR. The Ly-49D receptor activates murine natural killer cells. J Exp Med. 184:1996;2119-2128.
40. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. of outstanding interest Nature. 391:1998;703-707 The killer activating receptors (KARs) do not express an immunoreceptor tyrosine-based activation motif (ITAM) sequence in their cytoplasmic domain. This study describes the cloning of human DAP12, which encodes a cytoplasmic protein with an ITAM sequence. In cell lines transfected with genes for one KAR and DAP12, DAP12 associates with the KAR and this association is necessary for tyrosine phosphorylation and upregulation of CD69, an activation marker.
41. Mason LH, Willette-Brown J, Anderson SK, Gosselin P, Shores EW, Love PE, Ortaldo JR, McVicar DW. Cutting edge: characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. of outstanding interest J Immunol. 160:1998;4148-4152 In this study, the mouse counterpart of DAP-12 is described and results are in agreement with [40].
42. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol. 11:1993;613-635.
43. Timonen T. Natural killer cells: endothelial interactions, migration, and target cell recognition. J Leukocyte Biol. 62:1997;693-700.
44. Seebach JD, Waneck GL. Natural killer cells in xenotransplantation. Xenotransplantation. 4:1997;201-211.
45. Karlhofer FM, Hunziker R, Reichlin A, Margulies DH, Yokoyama WM. Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J Immunol. 153:1994;2407-2416.
46. Dorfman JR, Raulet DH. Acquisition of Ly49 receptor expression by developing natural killer cells. of special interest J Exp Med. 187:1998;609-618 In this paper the developmental time course of expression of Ly-49 receptors on NK cells was studied. Ly-49 receptor expression reached adult levels at about six-eight weeks of age in mice and the appearance of Ly-49 receptors on splenic NK cells coincided with the development of NK cell function. By adoptively transferring NK cells which expressed only one Ly-49 receptor into Ly5-congenic hosts, the authors observed that upregulation of other Ly-49 receptors occurred on the transferred NK cells but the original Ly-49 receptor continued to be expressed post-transfer. These data suggest that Ly-49 receptor expression is consecutive in nature.
47. Raulet DH, Held W, Correa I, Dorfman JR, Wu M-F, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev. 155:1997;41-52.
48. Poggi A, Mingari MC. Development of human NK cells from the immature cell precursors. Semin Immunol. 7:1995;61-66.
49. Puzanov IJ, Bennett M, Kumar V. Il-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol. 157:1996;4282-4285.
50. Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol. 27:1997;1374-1380.
51. Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, Waldmann TA, Taniguchi T, Taki S. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature. 391:1998;700-703.
52. Sentman CL, Olsson MY, Karre K. Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self. Semin Immunol. 7:1995;109-110.
53. Olsson MY, Karre K, Sentman CL. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc Natl Acad Sci USA. 92:1995;1649-1653.
54. Held W, Dorfman JR, Wu M-F, Raulet DH. Major histocompatibility complex class I-dependent skewing of the natural killer cells Ly49 receptor repertoire. Eur J Immunol. 26:1996;2286-2292.
55. Salcedo M, Diehl AD, Olsson-Alheim MY, Sundback J, Kaer LV, Karre K, Ljunggren H-G. Altered expression of Ly-49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol. 158:1997;3174-3180.
56. Zijlstra M, Auchincloss H Jr, Loring JM, Chase CM, Russell PS, Jaenisch R. Skin graft rejection by beta2-microglobulin-deficient mice. J Exp Med. 175:1992;885-893.
57. Yu YYL, George T, Dorfman JR, Roland J, Kumar V, Bennett M. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity. 4:1996;67-76.
58. b bone marrow allografts in mice. Int Immunol. 8:1997;1833-1839.
59. Bix M, Liao N-S, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature. 349:1991;329-331.
60. Lee LA, Sergio JJ, Sykes M. Natural killer cells weakly resist engraftment of allogeneic long-term multilineage-repopulating hematopoietic stem cells. Transplantation. 61:1996;125-132.
61. Aguila HL, Weissman IL. Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood. 87:1996;1225-1231.
62. Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J Immunol. 160:1998;87-94.
63. O'Reilly RJ, Brochstein J, Collins N, Keever C, Kapoor N, Kirkpatrick D, Keman NA, Dupont B, Burns J, Reisner Y. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sang. 51:1986;81-86.
64. Sharabi Y, Aksentijevich I, Sundt TM III, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med. 172:1990;195-202.
65. Gourlay WA, Chambers WH, Monaco AP, Maki T. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation. 65:1998;727-734.
66. Lin Y, Vandeputte M, Waer M. NK cell- and macrophage-mediated rejection of concordant xenografts in the absence of T- and B-cell responses. J Immunol. 158:1997;5658-5667.
67. Donnelly CE, Yatko C, Johnson EW, Edge ASB. Human natural killer cells account for non-MHC class I-restricted cytolysis of porcine cells. Cell Immunol. 175:1997;171-178.
68. Chan DV, Auchincloss H Jr. Human anti-pig cell-mediated cytotoxicity in vitro involves non-T as well as T cell components. Xenotransplantation. 3:1996;158-165.
69. Seebach JD, Yamada K, McMorrow IM, Sachs DH, DerSimonian H. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation. 3:1996;188-197.
70. Smyth MJ, Thia KYT, Kershaw MH. Xenogeneic mouse anti-human NK cytotoxicity is mediated via perforin. Xenotransplantation. 4:1997;78-84.
71. Leibson PJ. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity. 6:1997;655-661.
72. Pinola M, Renkonen R, Majuri ML, Tiisala S, Sakurada K. Characterization of the E-selectin ligand on NK cells. J Immunol. 152:1994;3586-3594.
73. Goodman DJ, von Albertini M, Willson A, Millan MT, Bach FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation. 61:1996;763-771.
74. Candinas D, Belliveau S, Koyamada N, Miyatake T, Hechenleitner P, Mark W, Bach FH, Hancock WW. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation. 62:1998;1920-1927.
75. Galili U. Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today. 14:1998;480-482.
76. Inverardi L, Clissi B, Stolzer AL, Bender JR, Sandrin MS, Pardi R. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. of outstanding interest Transplantation. 63:1997;1318-1330 In this study, a panel of carbohydrates was used to assess whether human NK cells could recognize carbohydrate residues on porcine endothelial cells (ECs). Coculture of the human NK cells and porcine ECs, in the presence of the specific carbohydrate epitopes, blocked the adhesion of NK cells to the ECs and also inhibited lysis of the ECs by the NK cells. Human NK cells adhered to COS-7 transfectants expressing the Gal epitope, demonstrating that NK cells can directly recognize carbohydrate antigens. These findings are important given the known role of the Gal epitope as a barrier to xenotransplantation.
77. + NK cell clones to lyse them. These results suggest that NK cells, in human recipients of transplants from donor pigs that are transgenic for HLA molecules, may not be able to reject transplants from such pigs.